drugset / Trial / NCT03463499

The Efficacy and Safety of Intravesical Hyaluronic Acid and Chondroitin Sulfate After Transurethral Resection of Hunner Lesion in Interstitial Cystitis/Bladder Pain Syndrome Patients

NCT03463499

Completed 62 enrolled Samsung Medical Center
NaSingle-groupOpen-labelTreatment

Summary

The efficacy and safety of intravesical hyaluronic acid and chondroitin sulfate after transurethral resection of Hunner lesion in interstitial cystitis/bladder pain syndrome patients. To analyze the number and timing of recurrence based on a long-term follow-up.

Timeline

Start
2017-09-22
Primary completion
2019-09-30
Completion
2021-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Chondroitin sulfate Unknown Other
Subject Hyaluronic Acid Other / unclassified Other

Indications